The measurement of willingness to pay for mass cancer screening with whole-body PET (positron emission tomography)
暂无分享,去创建一个
Kazuhiko Ohe | Hideo Yasunaga | Tomoaki Imamura | H. Yasunaga | K. Ohe | H. Ide | T. Imamura | Hiroo Ide
[1] S. Yasuda,et al. Application of positron emission tomography imaging to cancer screening , 2000, British Journal of Cancer.
[2] J. Olsen,et al. Theory versus practice: a review of 'willingness-to-pay' in health and health care. , 2001, Health economics.
[3] M. Drummond,et al. Health Care Technology: Effectiveness, Efficiency and Public Policy@@@Methods for the Economic Evaluation of Health Care Programmes , 1988 .
[4] Liang-Kuang Chen,et al. Application of PET and PEt/CT imaging for cancer screening. , 2004, Anticancer research.
[5] M. Johannesson,et al. Use of contingent valuation to place a monetary value on pharmacy services: an overview and review of the literature. , 1999, Clinical therapeutics.
[6] O. Schober,et al. Is whole-body FDG-PET valuable for health screening? , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[7] A Gafni,et al. Health care contingent valuation studies: a review and classification of the literature. , 1998, Health economics.
[8] F. Papatheofanis. The willingness to pay for positron emission tomography (PET): evaluation of suspected lung cancer using contingent valuation. , 2000, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.
[9] Richard D. Smith. Construction of the contingent valuation market in health care: a critical assessment. , 2003, Health economics.
[10] Papatheofanis Fj. The willingness to pay for positron emission tomography (PET): evaluation of suspected lung cancer using contingent valuation. , 2000 .
[11] M. Drummond,et al. Assessment of health producing measures across different sectors. , 1995, Health policy.
[12] P. Shackley,et al. Willingness to pay for antenatal carrier screening for cystic fibrosis. , 1995, Health economics.
[13] M. Ide,et al. Is whole-body FDG-PET valuable for health screening? , 2005, European Journal of Nuclear Medicine and Molecular Imaging.
[14] T Klose,et al. The contingent valuation method in health care. , 1999, Health policy.
[15] M. Weinstein,et al. What Do Patients Value?: Willingness to Pay for Ultrasound in Normal Pregnancy , 1985, Medical care.
[16] Amiram Gafni,et al. When Do the "Dollars" Make Sense? , 1996, Medical decision making : an international journal of the Society for Medical Decision Making.